On the way to maximising the potential of oligo-based medicine.
SMi’s inaugural Oligonucleotide Therapeutics and Delivery conference is here to keep you updated. By bringing together leading representatives of pharmaceutical, biotechnology and academic institutions, the 2-day conference will provide first-hand information on the latest clinical trial candidates and a platform for exchanging ideas for tackling the biggest challenge: DELIVERY. From optimizing particle size to choosing the right nanocarrier systems, the conference will address delivery to non-hepatocyte cells such as cancerous tissues and overview the most successful platforms. Discussions will be centered around improving targeted therapy uniting the field’s biggest players to share their opinions.
Established on the success of our RNA Therapeutics series, we look forward to welcoming you at Oligonucleotide Therapeutics and Delivery to join the conversation around maximizing the potential of oligo-based treatments.
Benefits of attending:
Plus, an interactive half day pre-conference workshop on Oligonucleotide drug discovery: Target selection, delivery, molecular design and lead identification.
CHAIR FOR 2020:
• Nagy Habib, Head of HBP Surgery, Imperial College London and Co-Founder, Head CNN of R&D and Chief Medical Officer, Mina Therapeutics
SCIENTIFIC ADVISORY BOARD 2020:
• Ekkehard Leberer, Senior Director, Alliance Management, Sanofi
• Mark Edbrooke, Independent Consultant
• Troels Koch, Chief Technology Officer, SVP Science and Technology, Inexos Therapeutics
• Sudhir Agrawal, Founder and President, ARNAY Sciences and Idera Pharma and Professor, University of Massachusetts Medical School
FEATURED 2020 SPEAKERS INCLUDE:
• David Evans, Chief Scientific Officer, Sirnaomics
• Alexey Wolfson, CEO, Advirna
• Stefan Vonhoff, VP Chemistry & Manufacturing, NOXXON Pharma
• Vera Brinks, Director Pharmaceutics, ProQR Therapeutics
• Matthew Catley, Research Director, MiNa Therapeutics
• Steve Pascolo, Founder and CEO, Miescher Pharma
Who should attend:
- RNA Biology/Discovery
-Novel Therapeutic Modalities
-Innovation Technologies
-C-level Scientific Executives
-Formulation and Drug Delivery
-Clinical Research and Development
-Cell Biology
EARLY-BIRD RATES:
Additional Contact Info:
T: +44 (0)20 7827 6088
E: hsidhu@
LinkedIn: @SMi Pharma Twitter: #SMiOligonucleotides
16 Sep 2020 @ 09:00 am
17 Sep 2020 @ 05:00 pm
Duration: 1 days, 8 hours
Holiday Inn Kensington Forum, London
97 Cromwell Road
SW7 4DN London
United Kingdom
English en